Neurogastrx, Inc.
Industry
- Biotechnology
- Pharmaceuticals
- Specialty Pharmaceuticals
- Vaccines
See more in Biomedtracker
Latest on Neurogastrx, Inc.
Scrip
• By Joseph Haas
Privately held Neurogastrx thinks it has a potential blockbuster with a Phase II candidate that can reduce the nausea and vomiting associated with GLP-1 therapies for obesity, type 2 diabetes and othe
Scrip
• By Mandy Jackson
The amount of venture capital raised during the second quarter of 2021 was almost double the total raised in the second quarter of 2020, but the biggest reason that biopharma financings jumped from $3
Scrip
• By Ian Haydock, Anju Ghangurde, Jung Won Shin, Brian Yang, and Joseph Haas
Heartseed Gets $55m Up Front Japanese bioventure Heartseed Inc. and Novo Nordisk A/S announced a worldwide collaboration and license agreement on 1 June for the development, manufacture and commer